What is AI Optics?
AI Optics operates at the intersection of advanced medical imaging and artificial intelligence, providing a robust suite of diagnostic tools designed for scalability. The company's flagship offering, the FDA-cleared Sentinel Camera, serves as a cornerstone for digital eye health, enabling primary care providers and optometrists to perform high-fidelity screenings with unprecedented ease. By integrating sophisticated AI-based disease screening software, AI Optics effectively bridges the gap between complex clinical diagnostics and routine patient care. Their strategic focus on the Sentinel Pro platform further demonstrates a commitment to addressing critical health challenges, such as Diabetic Retinopathy and Glaucoma, by delivering cost-effective, accessible solutions to health systems and private practices globally. This technological infrastructure is engineered to simplify implementation, ensuring that high-quality diagnostic capabilities are not confined to specialized centers but are available at the point of care.
How much funding has AI Optics raised?
AI Optics has raised a total of $14.7M across 1 funding round:
Stock/Share Issuance
$14.7M
Stock/Share Issuance (2025): $14.7M, investors not publicly disclosed
Key Investors in AI Optics
AI Optics
Undisclosed investor participating in the funding round.
What's next for AI Optics?
With this major strategic investment, AI Optics is poised to transition from a high-growth startup to an enterprise-level leader in the medical technology space. The capital will likely be deployed to scale the commercial rollout of the Sentinel Pro, expand the company's footprint across diverse healthcare networks, and refine its machine learning algorithms to enhance diagnostic accuracy. As the firm navigates this growth phase, the focus will remain on deepening its integration within existing health systems and exploring new clinical applications for its imaging software. By prioritizing accessibility and operational efficiency, AI Optics is strategically positioned to capture a larger share of the diagnostic market, ultimately setting a new standard for preventative eye care and patient-centric health outcomes.
See full AI Optics company page
